GlassScriptPhysician profile
David R Neff
NPI 1740326800
$667.46
in general payments reported to CMS, 2019-2025
17 companies · $57.04 in 2025
The $57.04 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.05 · 2022: $159 · 2023: $356 · 2024: $83.39 · 2025: $57.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $496.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $495.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $95.95 | 2022-2023 | Ozempic, Rybelsus |
| Amgen INC. | $85.15 | 2022 | |
| Braeburn INC. | $68.91 | 2024 | Brixadi |
| Abbvie INC. | $67.73 | 2023 | |
| Otsuka America Pharmaceutical, INC. | $60.25 | 2023-2025 | Rexulti |
| Bayer Healthcare Pharmaceuticals INC. | $54.92 | 2022-2023 | |
| Boston Scientific Corporation | $31.98 | 2024-2025 | General - Pain Management |
| Glaxosmithkline, LLC. | $30.03 | 2022-2023 | Trelegy Ellipta |
| Alkermes, INC. | $24.98 | 2023 | Vivitrol |
| Novartis Pharmaceuticals Corporation | $24.63 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $24.27 | 2023 | Trintellix |
| Exact Sciences Corporation | $22.83 | 2023 | Cologuard Collection Kit |
| Antares Pharma, INC. | $18.24 | 2023 | Xyosted, Tlando, Nocdurna |
| Lilly USA, LLC | $17.68 | 2023 | Mounjaro, Trulicity |
| Astrazeneca Pharmaceuticals LP | $14.40 | 2023 | Farxiga |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Halozyme INC | $13.46 | 2023 | |
| Becton, Dickinson and Company | $12.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Neff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.